Sensei Biotherapeutics GAAP EPS of -$2.84 (FTH:NASDAQ)
· seekingalpha.com
Sensei Biotherapeutics (FTH) Q2 results: GAAP EPS -$2.84, cash jumps to $186.4M, and R&D/G&A rise on trials and financing—read the highlights now.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...